ELZONRIS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 04 Oct 2025)
What this means for you
Registered since 18 Jun 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87843152
- Registration number
- 5782895
- Mark type
- Stylized text
- Filed
- 21 Mar 2018
- Published for opposition
- 12 Feb 2019
- Registered
- 18 Jun 2019
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the diagnosis and treatment of cancer and auto-immune diseases; drug delivery agent in the form of infusion for the diagnosis and treatment of cancer and auto-immune diseases
Owner
- Stemline Therapeutics, Inc., New York, NY, US
- Stemline Therapeutics, Inc., New York, NY, US
- Stemline Therapeutics, Inc., New York, NY, US
Prosecution history
- 04 Oct 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Oct 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Oct 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Jun 2025 — TEAS SECTION 8 & 15 RECEIVED
- 18 Jun 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Jun 2019 — REGISTERED-PRINCIPAL REGISTER
- 16 May 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 May 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Apr 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Apr 2019 — USE AMENDMENT FILED
- 23 Apr 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Apr 2019 — TEAS STATEMENT OF USE RECEIVED
- 09 Apr 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Feb 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Feb 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED